Dementia Discovery Fund - aVenture Asset Manager Research
Dementia Discovery Fund
Operating Status: Operating
World's largest venture fund specializing in dementia therapeutics, leveraging global partnerships for impactful, profitable investments.
Location
London, Greater London, GB
Founded
2015
The Dementia Discovery Fund (DDF) is the world's largest specialized venture capital fund focusing exclusively on novel therapeutics for dementia, including Alzheimer's Disease. Managed by SV Health Investors, DDF has raised over $500 million to invest in companies addressing this significant unmet medical need. With offices in London and Boston, the fund capitalizes on global investment opportunities across various stages, from seed to later rounds.
DDF's portfolio includes notable companies such as Alector, Cerevance, and QurAlis. The fund's investment strategy targets innovative approaches to dementia treatment, leveraging its expertise and global partnerships to support portfolio companies. DDF's unique focus and substantial resources position it as a key player in advancing dementia therapeutics and potentially transforming patient outcomes in this critical field.
Dementia Discovery Fund - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
